MENU
+Compare
SNGX
Stock ticker: NASDAQ
AS OF
May 14, 04:49 PM (EDT)
Price
$1.90
Change
+$0.03 (+1.60%)
Capitalization
6M

SNGX Soligenix Inc. Forecast, Technical & Fundamental Analysis

Soligenix Inc is a late-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SNGX with price predictions
May 13, 2025

Momentum Indicator for SNGX turns negative, indicating new downward trend

SNGX saw its Momentum Indicator move below the 0 level on April 30, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In of the 83 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for SNGX turned negative on May 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where SNGX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SNGX advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.433) is normal, around the industry mean (14.420). P/E Ratio (0.000) is within average values for comparable stocks, (65.047). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.146). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (254.920).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SNGX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNGX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SNGX is expected to report earnings to rise 15.38% to -150 cents per share on May 12

Soligenix Inc. SNGX Stock Earnings Reports
Q1'23
Est.
$-1.50
Q4'22
Missed
by $0.17
Q3'22
Beat
by $0.02
Q2'22
Beat
by $0.02
Q1'22
Missed
by $0.03
The last earnings report on March 28 showed earnings per share of -129 cents, missing the estimate of -112 cents. With 13.77K shares outstanding, the current market capitalization sits at 6.00M.
A.I. Advisor
published General Information

General Information

a manufacturer of biodefense vaccines and oral therapeutic products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
29 Emmons Drive
Phone
+1 609 538-8200
Employees
15
Web
https://www.soligenix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVER24.900.80
+3.32%
EverQuote
TZOO14.510.29
+2.04%
Travelzoo
HIW30.460.05
+0.16%
Highwoods Properties
STSS4.55-0.11
-2.36%
Sharps Technology Inc
FND81.50-2.30
-2.74%
Floor & Decor Holdings

SNGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been loosely correlated with THAR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNGX jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
-4.35%
THAR - SNGX
46%
Loosely correlated
-7.69%
VRAX - SNGX
36%
Loosely correlated
-1.40%
QURE - SNGX
36%
Loosely correlated
-2.59%
ATHA - SNGX
31%
Poorly correlated
+3.70%
LGVN - SNGX
30%
Poorly correlated
-2.04%
More